Clinical aspects of hypertensive myocardial fibrosis

被引:107
作者
Díez, J
López, B
Gonzádlez, A
Querejeta, R
机构
[1] Univ Navarra, Fac Med, Dept Cardiovasc Pathophysiol, Sch Med, Pamplona 31080, Spain
[2] Univ Navarra, Univ Clin, Dept Cardiol & Cardiovasc Surg, E-31080 Pamplona, Spain
[3] Ntra Sra Aranzazu Hosp, Div Cardiol, San Sebastian, Spain
关键词
D O I
10.1097/00001573-200111000-00003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myocardial fibrosis is one of the histologic constituents of myocardial remodeling present in hypertensive patients with hypertensive heart disease. In fact, an exaggerated interstitial and perivascular accumulation of fibrillar collagens type I and type III has been found in the myocardium of patients with arterial hypertension and left ventricular hypertrophy. Hypertensive myocardial fibrosis has been shown to facilitate abnormalities of cardiac function, coronary reserve, and electrical activity that adversely affect the clinical outcome of hypertensive patients. Therefore, development of noninvasive tools for the monitoring of myocardial fibrosis and pharmacological strategies aimed to promote the regression of fibrosis could be of particular relevance in the clinical treatment of patients with hypertensive heart disease. (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:328 / 335
页数:8
相关论文
共 50 条
  • [1] AMANUMA S, 1994, POSTGRAD MED J, V70, pS67
  • [2] Compensated cardiac hypertrophy: Arrhythmogenicity and the new myocardial phenotype .1. Fibrosis
    Assayag, P
    Carre, F
    Chevalier, B
    Delcayre, C
    Mansier, P
    Swynghedauw, B
    [J]. CARDIOVASCULAR RESEARCH, 1997, 34 (03) : 439 - 444
  • [3] Regulation of cardiovascular collagen synthesis by mechanical load
    Bishop, JE
    Lindahl, G
    [J]. CARDIOVASCULAR RESEARCH, 1999, 42 (01) : 27 - 44
  • [4] ANGIOTENSIN-II TYPE-1 RECEPTOR GENE POLYMORPHISMS IN HUMAN ESSENTIAL-HYPERTENSION
    BONNARDEAUX, A
    DAVIES, E
    JEUNEMAITRE, X
    FERY, I
    CHARRU, A
    CLAUSER, E
    TIRET, L
    CAMBIEN, F
    CORVOL, P
    SOUBRIER, F
    [J]. HYPERTENSION, 1994, 24 (01) : 63 - 69
  • [5] Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease
    Brilla, CG
    Funck, RC
    Rupp, H
    [J]. CIRCULATION, 2000, 102 (12) : 1388 - 1393
  • [6] Echocardiographic patterns of myocardial fibrosis in hypertensive patients: Endomyocardial biopsy versus ultrasonic tissue characterization
    Ciulla, M
    Paliotti, R
    Hess, DB
    Tjahja, E
    Campbell, SE
    Magrini, F
    Weber, KT
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 1997, 10 (06) : 657 - 664
  • [7] LEFT-VENTRICULAR HYPERTROPHY AND IMPAIRED DIASTOLIC FILLING IN ESSENTIAL-HYPERTENSION - DIASTOLIC MECHANISMS FOR SYSTOLIC DYSFUNCTION DURING EXERCISE
    CUOCOLO, A
    SAX, FL
    BRUSH, JE
    MARON, BJ
    BACHARACH, SL
    BONOW, RO
    [J]. CIRCULATION, 1990, 81 (03) : 978 - 986
  • [8] DAVIDSON CJ, 2001, HEART DIS TXB CARDIO, P359
  • [9] The potential prognostic value of ultrasonic characterization (videodensitometry) of myocardial tissue in essential arterial hypertension
    Di Bello, V
    Pedrinelli, R
    Giorgi, D
    Bertini, A
    Talini, E
    Caputo, MT
    Dell'Omo, G
    Cioppi, A
    Moretti, L
    Paterni, M
    Giusti, C
    [J]. CORONARY ARTERY DISEASE, 2000, 11 (07) : 513 - 521
  • [10] Microalbuminuria, pulse pressure, left ventricular hypertrophy, and myocardial ultrasonic tissue characterization in essential hypertension
    Di Bello, V
    Pedrinelli, R
    Giorgi, D
    Bertini, A
    Caputo, MT
    Cioppi, A
    Talini, E
    Leonardo, M
    Dell'Omo, G
    Paterni, M
    Giusti, C
    [J]. ANGIOLOGY, 2001, 52 (03) : 175 - 183